VENUSREMVENUS REMEDIES LTD.Venus Remedies Q1 FY27: consolidated PAT jumps ~139% YoY to ₹22.97 Cr, margins expandPharma & Biotech · earnings · quarterly resultsResultsQ1 FY273 minPharma & Healthcare
MANGALAMMANGALAM DRUGS & ORGANICS LTD.Mangalam Drugs: The Default Signal — Balance Sheet Under Pressuredistress · bank default · micro-capResearchDeep dive6 minPharma & Healthcare
VIKASECOVIKASLIFE+1The ED's Cross-Company Enforcement: The Vikas Garg PatternED enforcement · PMLA · regulatory riskResearchDeep dive7 minPharma & Healthcare
NATCOPHARMNATCO PHARMA LTD.Natco's African Wager: ₹1,060 Crore Bet on South Africa's Pharmacycross-border M&A · South Africa · Adcock IngramResearchDeep dive5 minPharma & Healthcare